Parent Page: About id: 23950 Active Page: Researchid:23959


OU College of Medicine Awarded $11 Million Grant to Study Infections
The University of Oklahoma College of Medicine has been awarded an $11 million federal grant to create the Oklahoma Center for Microbial Pathogenesis and Immunity, a hub for research into many types of infections and how the immune system recognizes and destroys them, or succumbs to them…More

OU College of Medicine Researchers Make Discovery About Pancreatic Cancer Drug Resistance
One of the biggest barriers in treating pancreatic cancer is that it becomes resistant to chemotherapy and its rapid growth cannot be stopped...More

OU Reproductive Medicine Physician Receives Grant to Further Study Frozen Embryo Transfers
For couples who are unable to conceive a child on their own, in vitro fertilization has fulfilled many dreams of welcoming a baby into the family. Physicians at OU Medicine regularly perform IVF for patients and, as part of an academic medical center, they also conduct research to refine the procedure in order to achieve the best health outcomes for both mother and baby...More

OU Health Sciences Center Diabetic Retinopathy Research Commercialized to Work Toward New Treatment
In people with diabetes, diabetic retinopathy is a frequent complication and the most common cause of vision loss. To curtail the prevalence of the devastating eye disease, University of Oklahoma researchers on both the Oklahoma City and Norman campuses have launched a pharmaceutical company to develop a new treatment…More

Stephenson Cancer Center Participating in COVID-19 Trials
Stephenson Cancer Center at OU Medicine is participating in two clinical trials sponsored by the National Cancer Institute that will investigate the health of patients with cancer who are infected with the COVID-19 virus…More

OU Health Sciences Center Researcher Joins COVID-19 Vaccine Project
The University of Oklahoma Health Sciences Center has launched a research collaboration with Pure MHC, an innovative biotechnology company, to work toward the development of a vaccine for the COVID-19 virus…More